Term of use
The information contained in this website is not for promotional purposes nor does it constitute an offer or solicitation to prescribe, purchase or supply or market or any other transaction with regard to products distinguished by the Chiesi brand.
While it is the intention of Chiesi Farmaceutici to provide accurate and updated data on its Web site, Chiesi Farmaceutici does not accept any liability for errors, omissions or changes regarding the data provided. At the same time, Chiesi Farmaceutici reserves the right to make, without notice, any changes and updates deemed appropriate and useful.
Any form of reproduction of the information and images contained on this site is forbidden without the prior written consent of Chiesi Farmaceutici.
The images, text, video and audio elements and photographs (collectively referred to as "Material"), contained on the cystinosis-cdsp.com website are protected by copyright laws.
It is forbidden to reproduce, publish, send, transmit, distribute or otherwise use, in whole or in part, the "Material" of the cystinosis-cdsp.com website.
The "Material" on the cystinosis-cdsp.com website may be changed by the company without any prior notice whatsoever.
Campaign promoted by
Acknowledgements
The authors gratefully acknowledge the advice and guidance provided by the external experts, Dr Cyril Goizet and Dr Graham Lipkin.
The authors extend special thanks to Cystinosis Network Europe (CNE), at http://cystinosis-europe.eu for their insightful review of this document. CNE received no honorarium or payment for this review.
Medical writing support was provided by Vivid Medical Communications, a member of the Lucid Group.
Date of preparation: September 2021.
ALL_21_057.
Patients & Caregivers: in case of need to report an adverse drug reaction, please refer to your physician, asking him to fill in and submit the relevant case report to the concerned Health Authority, according to the Pharmacovigilance requirements in force in your Country. Nevertheless, please be kindly reminded that each patient can report any such cases directly to the national reporting system.
Healthcare Professionals: in case you want to report an adverse drug reaction you become aware of, please report it to your Health Authority according to the requirements set by the pharmacovigilance legislation.
This informational website is not intended for residents of the United States.